146 related articles for article (PubMed ID: 30614800)
1. Correlations of DKK1 with pathogenesis and prognosis of human multiple myeloma.
Feng Y; Zhang Y; Wei X; Zhang Q
Cancer Biomark; 2019; 24(2):195-201. PubMed ID: 30614800
[TBL] [Abstract][Full Text] [Related]
2. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
3. Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
Fulciniti M; Tassone P; Hideshima T; Vallet S; Nanjappa P; Ettenberg SA; Shen Z; Patel N; Tai YT; Chauhan D; Mitsiades C; Prabhala R; Raje N; Anderson KC; Stover DR; Munshi NC
Blood; 2009 Jul; 114(2):371-9. PubMed ID: 19417213
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
[TBL] [Abstract][Full Text] [Related]
5. Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma.
Choi YW; Park JS; Han JH; Kim JH; Ahn MS; Lee HW; Kang SY; Choi JH; Jeong SH
Leuk Lymphoma; 2018 Nov; 59(11):2670-2678. PubMed ID: 29582699
[TBL] [Abstract][Full Text] [Related]
6. Correlations of DKK1 with incidence and prognosis of breast cancer.
Sun W; Shang J; Zhang J; Chen S; Hao M
J BUON; 2019; 24(1):26-32. PubMed ID: 30941948
[TBL] [Abstract][Full Text] [Related]
7. Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model.
Park BM; Kim EJ; Nam HJ; Zhang D; Bae CH; Kang M; Kim H; Lee W; Bogen B; Lim SK
Yonsei Med J; 2017 May; 58(3):505-513. PubMed ID: 28332354
[TBL] [Abstract][Full Text] [Related]
8. Dickkopf-1 is a novel prognostic biomarker for laryngeal squamous cell carcinoma.
Shi Y; Gong HL; Zhou L; Tian J; Wang Y
Acta Otolaryngol; 2014 Jul; 134(7):753-9. PubMed ID: 24834937
[TBL] [Abstract][Full Text] [Related]
9. Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype.
Xu WH; Liu ZB; Yang C; Qin W; Shao ZM
PLoS One; 2012; 7(5):e37624. PubMed ID: 22649545
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention.
Zhou F; Meng S; Song H; Claret FX
Blood Rev; 2013 Nov; 27(6):261-7. PubMed ID: 24054128
[TBL] [Abstract][Full Text] [Related]
12. Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.
Yaccoby S; Ling W; Zhan F; Walker R; Barlogie B; Shaughnessy JD
Blood; 2007 Mar; 109(5):2106-11. PubMed ID: 17068150
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma.
Kocemba KA; Groen RW; van Andel H; Kersten MJ; Mahtouk K; Spaargaren M; Pals ST
PLoS One; 2012; 7(2):e30359. PubMed ID: 22363428
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
[TBL] [Abstract][Full Text] [Related]
15. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.
Gunn WG; Conley A; Deininger L; Olson SD; Prockop DJ; Gregory CA
Stem Cells; 2006 Apr; 24(4):986-91. PubMed ID: 16293576
[TBL] [Abstract][Full Text] [Related]
16. Serum DKK1 is correlated with γ peak of serum electrophoresis in multiple myeloma: a multicenter biomarker study.
Hashemi ZS; Khalili S; Malaei F; Mard-Soltani M; Jafarisani M; Lotfi J; Deemeh MR; Zakeri A; Rasaee MJ
Biomark Med; 2019 Oct; 13(15):1297-1306. PubMed ID: 31596134
[No Abstract] [Full Text] [Related]
17. Elevated levels of Dickkopf-1 are associated with β-catenin accumulation and poor prognosis in patients with chondrosarcoma.
Chen C; Zhou H; Zhang X; Ma X; Liu Z; Liu X
PLoS One; 2014; 9(8):e105414. PubMed ID: 25144498
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf-1 has an Inhibitory Effect on Mesenchymal Stem Cells to Fibroblast Differentiation.
Li Y; Qiu SS; Shao Y; Song HH; Li GL; Lu W; Zhu LM
Chin Med J (Engl); 2016 May; 129(10):1200-7. PubMed ID: 27174329
[TBL] [Abstract][Full Text] [Related]
19. Dickkopf-1 in human oral cancer.
Ogoshi K; Kasamatsu A; Iyoda M; Sakuma K; Yamatoji M; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Int J Oncol; 2011 Aug; 39(2):329-36. PubMed ID: 21617850
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation.
Chu T; Teng J; Jiang L; Zhong H; Han B
Biochem Biophys Res Commun; 2014 Jan; 443(3):962-8. PubMed ID: 24361889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
